Returning to Stimulants in Children with Treatment Resistant ADHD: A Case Series.
نویسندگان
چکیده
Objective To present a case series of children retrialed on stimulants after initial poor stimulant responses given the paucity of information on the usefulness of this strategy. Methods Health records from an ADHD medication service were obtained for six children who: (i) were medication naïve at service entry; (ii) had trials of at least one stimulant from each stimulant class; (iii) subsequently received a non-stimulant ADHD medication; and, (iv) were then retried on stimulants. Results Initial stimulant discontinuation was a function of adverse effects and/or limited symptom improvement. Minimal response and/or adverse effects to non-stimulants contributed to the decision to retry stimulants. Final ADHD symptom ratings by parents and teachers were significantly better than baseline for this cohort. Three were discharged on stimulants, two as monotherapy. Conclusion Further study is required to develop evidence-based treatment algorithms for treatment resistant ADHD. Retrying a stimulant may be one option.
منابع مشابه
مقایسه اثربخشی داروی دولوکستین با متیلفنیدیت در درمان اختلال بیشفعالی کمتوجهی کودکان
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common and mostly chronic mental health condition that affects children, adolescents, and adults. Stimulants and atomoxetine are first-line agents for the treatment of ADHD. Despite the impressive track record of stimulants in the treatment of ADHD, they fail in 25% of patients due to lack of efficacy or the emergence of unwanted ...
متن کاملدرمان ششهفتهای با رباکستین در کودکان و نوجوانان مبتلا به اختلال بیشفعالی کمتوجهی
Background: Attention Deficit Hyperactivity Disorder (ADHD) is a common psychiatric disorder among children and adolescents. This disorder causes difficulties in academic, behavioral, emotional, social and family performance. Stimulants show robust efficacy and a good safety profile in children with this disorder, but a significant percent of ADHD children do not respond adequately or cannot to...
متن کاملAttention-Deficit/Hyperactivity Disorder and Herbal Medicine: An Evidenced Based Approach
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric disorders in children and adolescents with a worldwide prevalence of 5%. It is characterized by symptoms of attention deficit and/or hyperactivity/impulsiveness that is maintained for at least six months. ADHD is a neural disorder with structural and functional abnormalities in some areas of the brain. Pharmac...
متن کاملBlood Pressure, Heart Rate, and CNS Stimulant Medication Use in Children with and without ADHD: Analysis of NHANES Data
It is estimated that 2-3% of children in the US have hypertension (HTN) and 8% of children ages 4-17 carry the diagnosis of attention-deficit hyperactivity disorder (ADHD). The prevalence of HTN and cardiovascular (CV) risk factors in children with ADHD on CNS stimulant treatment (stimulants) compared to no treatment and compared to their healthy counterparts is not well described. Using Nation...
متن کاملMethylphenidate for psychosis and aggression in a patient comorbid with ADHD - A case report.
Attention-deficit/hyperactivity disorder (ADHD) may persist into adulthood in a substantial proportion of affected youth, with rates differing between 15 (persistence of full syndrome) and 65% (partial remission) (Faraone et al. 2005). There is ample evidence that patients suffering from ADHD carry a heightened risk for other psychiatric disorders. Adults with ADHD show high rates of comorbidit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent
دوره 27 1 شماره
صفحات -
تاریخ انتشار 2018